Applications:
Ingredient(s): Poly-DL-Lactic-co-Glycolic Acid
Dosage Form: Injectable / Parenteral
Category: Parenteral
Technical Specifications: Classic and ultrapure LMP
Applications:
Ingredient(s): PLGA Polymers
Dosage Form: Injectable / Parenteral
Category: Parenteral
Technical Specifications: Polylactide-co-glycolide (50:50); Intrinsic Viscosity: 15-25 mL/g, 25-35 mL/g, 35-45 mL/g
Applications:
Ingredient(s): Poly-DL-Lactic-co-Glycolic Acid
Dosage Form: Injectable / Parenteral
Category: Parenteral
Technical Specifications: Classic and ultrapure LMP
Applications:
Ingredient(s): PLGA Polymers
Dosage Form: Injectable / Parenteral
Category: Parenteral
Technical Specifications: Polylactide-co-glycolide (75:25); Intrinsic Viscosity: 20-30 mL/g, 30-40 mL/g, 40-50 mL/g
Applications:
Ingredient(s): Poly-DL-Lactic-co-Glycolic Acid
Dosage Form: Injectable / Parenteral
Category: Parenteral
Technical Specifications: Classic and ultrapure LMP
Applications:
Ingredient(s): PLGA Polymers
Dosage Form: Injectable / Parenteral
Category: Parenteral
Technical Specifications: Polylactide-co-glycolide (85:15); Intrinsic Viscosity: 15-25 mL/g, 25-35 mL/g, 50-60 mL/g
Applications:
Ingredient(s): Poly-DL-Lactic-co-Glycolic Acid
Dosage Form: Tablet
Category: Controlled & Modified Release
Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades.
Applications:
Ingredient(s): Poly DL Lactide co Glycolide
Dosage Form: Injectable / Parenteral, Tablet
Category: Controlled & Modified Release, Parenteral
Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades, available ratio PLGA 50:50, PLGA 75:25, PLGA 85:15, PLGA 55:45 Star Glucose, PLGA 65:35, PLGA 90:10.